// App-Quantinova.ai

TCT-201 : Impact of Proton Pump Inhibitors on Efficacy of Antiplatelet Strategies With Ticagrelor or Aspirin After Percutaneous Coronary Intervention

Researchers

Presenter

  • Masafumi Ono

Principal Investigators

  • Yoshinobu Onuma

  • Hideyuki Kawashima

  • Hironori Hara

  • Chao Gao

  • Rutao Wang

  • Neil O’Leary

  • Scot Garg

  • Peter Juni

  • Christian Hamm

  • Marco Valgimigli

  • Stephan Windecker

  • Pascal Vranckx

  • Efthymios Deliargyris

  • Deepak Bhatt

  • Robert Storey

  • Patrick Serruys

Medical Centers

  • Saolta Group, Galway University Hospital, Health Service Executive, and National University of Ireland Galway, Galway, Ireland

  • Hartcentre Hasselt, Hasselt, Belgium

  • Royal Blackburn Hospital, Blackburn, United Kingdom

  • National University of Ireland Galway, Galway, Ireland

  • Swiss Cardiovascular Center Bern, Bern, Switzerland

  • Kerckhoff Clinic, Bad Nauheim, Germany

  • Xijing Hospital, Xi'an, Shaanxi, China

  • University of Sheffield, Sheffield, United Kingdom

  • Istituto Cardiocentro Ticino-Ente Ospedaliero Cantonale, Lugano, Switzerland

  • Brigham and Women’s Hospital, Boston, Massachusetts, USA

  • Toronto, Ontario, Canada

Locations

  • Ireland

  • China

  • Belgium

  • United Kingdom

  • United States

  • Switzerland

  • Canada

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Central Nervous System (CNS)

Disease

  • Myocardial infarction

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • Ticagrelor

  • Aspirin

  • Albyl-E

Outcome

  • N/A


Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final